Osteogenic capacity of human BM-MSCs, AT-MSCs and their co-cultures using HUVECs in FBS and PL supplemented media

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 7, 2015, Pages 779-788

  Ma, Jinling ^a,b   van den Beucken, Jeroen J J P ^a   Both, Sanne K ^a   Prins, Henk Jan ^c   Helder, Marco N ^d   Yang, Fang ^a   Jansen, John A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone tissue engineering; Co culture; Fetal bovine serum; Osteogenesis; Platelet lysate; Stem cells

Indexed keywords

BONE; CELL CULTURE; CELL ENGINEERING; ENDOTHELIAL CELLS; FLOWCHARTING; TISSUE ENGINEERING;

ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS; BONE MARROW-DERIVED MESENCHYMAL STEM CELLS; BONE TISSUE ENGINEERING; BONE-MARROW-DERIVED MESENCHYMAL STEM CELLS; CO-CULTURES; FETAL BOVINE SERUM; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; OSTEOGENESIS; PLATELET LYSATE; STEM-CELL;

STEM CELLS;

CALCIUM; CULTURE MEDIUM;

ADIPOSE TISSUE CELL; ADULT; ARTICLE; BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CALCIFICATION; CELL DIFFERENTIATION; CELL LYSATE; CELL METABOLISM; CELL PROLIFERATION; COCULTURE; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MONOCULTURE; PRIORITY JOURNAL; THROMBOCYTE; UMBILICAL VEIN ENDOTHELIAL CELL; ADIPOSE TISSUE; BONE MARROW CELL; CHEMISTRY; CYTOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; PHARMACOLOGY; PROCEDURES;

ADIPOSE TISSUE; BONE MARROW CELLS; COCULTURE TECHNIQUES; CULTURE MEDIA; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MESENCHYMAL STROMAL CELLS;

EID: 84957839102     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1704     Document Type: Article

References (53)

1. Agata H, Watanabe N, Ishii Y et al. 2009; Feasibility and efficacy of bone tissue engineering using human bone marrow stromal cells cultivated in serum-free conditions. Biochem Biophys Res Commun 382: 353-358.
2. Aldahmash A, Haack-Sorensen M, Al-Nbaheen M et al. 2011; Human serum is as efficient as fetal bovine serum in supporting proliferation and differentiation of human multipotent stromal (mesenchymal) stem cells in vitro and in vivo. Stem Cell Rev 7: 860-868.
3. Baghaban Eslaminejad M, Nazarian H, Falahi F et al. 2009; Ex vivo expansion and differentiation of mesenchymal stem cells from goat bone marrow. Iran J Basic Med Sci 12: 70-79.
4. Bieback K, Hecker A, Kocaomer A et al. 2009; Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27: 2331-2341.
5. Blande IS, Bassaneze V, Lavini-Ramos C et al. 2009; Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate. Transfusion 49: 2680-2685.
6. Chevallier N, Anagnostou F, Zilber S et al. 2010; Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials 31: 270-278.
7. Cho HS, Song IH, Park SY et al. 2011; Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells. Korean J Lab Med 31: 212-218.
8. de Girolamo L, Arrigoni E, Stanco D et al. 2011; Role of autologous rabbit adipose-derived stem cells in the early phases of the repairing process of critical bone defects. J Orthop Res 29: 100-108.
9. Deans RJ, Moseley AB. 2000; Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28: 875-884.
10. Doucet C, Ernou I, Zhang Y et al. 2005; Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205: 228-236.
11. Friedman MS, Long MW, Hankenson KD. 2006; Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 98: 538-554.
12. Giannobile WV, Whitson SW, Lynch SE. 1997; Non-coordinate control of bone formation displayed by growth factor combinations with IGF-I. J Dent Res 76: 1569-1578.
13. Grellier M, Bordenave L, Amedee J. 2009; Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol 27: 562-571.
14. Grewal NS, Gabbay JS, Ashley RK et al. 2009; BMP-2 does not influence the osteogenic fate of human adipose-derived stem cells. Plast Reconstr Surg 123: 158S-165S.
15. Gruber R, Karreth F, Kandler B et al. 2004; Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets 15: 29-35.
16. Horn P, Bokermann G, Cholewa D et al. 2010; Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy 12: 888-898.
17. Huang Z, Ren PG, Ma T et al. 2010; Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine 51: 305-310.
18. Janicki P, Boeuf S, Steck E et al. 2011; Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells. Eur Cell Mater 21: 488-507.
19. Kaigler D, Krebsbach PH, Wang Z et al. 2006; Transplanted endothelial cells enhance orthotopic bone regeneration. J Dent Res 85: 633-637.
20. Kim JY, Jin GZ, Park IS et al. 2010; Evaluation of solid free-form fabrication-based scaffolds seeded with osteoblasts and human umbilical vein endothelial cells for use in vivo osteogenesis. Tissue Eng Part A 16: 2229-2236.
21. Kocaoemer A, Kern S, Kluter H et al. 2007; Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25: 1270-1278.
22. Koch TG, Heerkens T, Thomsen PD et al. 2007; Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol 7: 26.
23. Lange C, Cakiroglu F, Spiess AN et al. 2007; Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213: 18-26.
24. Lendeckel S, Jodicke A, Christophis P et al. 2004; Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg 32: 370-373.
25. Liu TM, Martina M, Hutmacher DW et al. 2007; Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 25: 750-760.
26. Lucchini G, Introna M, Dander E et al. 2010; Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population. Biol Blood Marrow Transplant 16: 1293-1301.
27. Ma J, van den Beucken JJ, Yang F et al. 2010; Co-culture of osteoblasts and endothelial cells: optimization of culture medium and cell ratio. Tissue Eng Part C Methods 17: 349-357.
28. Mankani MH, Kuznetsov SA, Wolfe RM et al. 2006; In vivo bone formation by human bone marrow stromal cells: reconstruction of the mouse calvarium and mandible. Stem Cells 24: 2140-2149.
29. Marcacci M, Kon E, Moukhachev V et al. 2007; Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 13: 947-955.
30. Martin MJ, Muotri A, Gage F et al. 2005; Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11: 228-232.
31. Massberg S, Konrad I, Schurzinger K et al. 2006; Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 203: 1221-1233.
32. Meijer GJ, de Bruijn JD, Koole R et al. 2008; Cell based bone tissue engineering in jaw defects. Biomaterials 29: 3053-3061.
33. Morishita T, Honoki K, Ohgushi H et al. 2006; Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients' mesenchymal stem cells. Artif Organs 30: 115-118.
34. Muller AM, Davenport M, Verrier S et al. 2009; Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue. Tissue Eng Part A 15: 869-875.
35. Naaijkens BA, Niessen HW, Prins HJ et al. 2012; Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications. Cell Tissue Res 348: 119-130.
36. Pachon-Pena G, Yu G, Tucker A et al. 2011; Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immunophenotypic profiles. J Cell Physiol 226: 843-851.
37. Peter SJ, Liang CR, Kim DJ et al. 1998; Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-ascorbic acid. J Cell Biochem 71: 55-62.
38. Pittenger MF, Mackay AM, Beck SC et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
39. Prins HJ, Rozemuller H, Vonk-Griffioen S et al. 2009; Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum. Tissue Eng Part A 15: 3741-3751.
40. Rodrigues M, Griffith LG, Wells A. 2010; Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther 1: 32.
41. Salvade A, Della Mina P, Gaddi D et al. 2010; Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Eng Part C Methods 16: 201-214.
42. Santos MI, Reis RL. 2010; Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 10: 12-27.
43. Schallmoser K, Bartmann C, Rohde E et al. 2007; Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47: 1436-1446.
44. Schallmoser K, Rohde E, Reinisch A et al. 2008; Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods 14: 185-196.
45. Seebach C, Henrich D, Kahling C et al. 2010; Endothelial progenitor cells and mesenchymal stem cells seeded onto beta-TCP granules enhance early vascularization and bone healing in a critical-sized bone defect in rats. Tissue Eng Part A 16: 1961-1970.
46. Shih DT, Chen JC, Chen WY et al. 2011; Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally inactivated allogeneic human platelet lysate. Transfusion 51: 770-778.
47. Soffer E, Ouhayoun JP, Dosquet C et al. 2004; Effects of platelet lysates on select bone cell functions. Clin Oral Implants Res 15: 581-588.
48. Song H, Wang Z, Zhao Y et al. 2008; Interventional effect of platelet lysate on osteogenic differentiation of BMSCs in rats. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22: 737-741.
49. Thesleff T, Lehtimaki K, Niskakangas T et al. 2011; Cranioplasty with adipose-derived stem cells and biomaterial: a novel method for cranial reconstruction. Neurosurgery 68: 1535-1540.
50. Varma MJ, Breuls RG, Schouten TE et al. 2007; Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells. Stem Cells Dev 16: 91-104.
51. von Bonin M, Stolzel F, Goedecke A et al. 2009; Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 43: 245-251.
52. Zhou J, Lin H, Fang TL et al. 2010; The repair of large segmental bone defects in the rabbit with vascularized tissue engineered bone. Biomaterials 31: 1171-1179.
53. Zuk P, Chou YF, Mussano F et al. 2011; Adipose-derived stem cells and BMP2: part 2. BMP2 may not influence the osteogenic fate of human adipose-derived stem cells. Connect Tissue Res 52: 119-132.